Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.
    Difference
    4%
    Check dated 2025-07-11T07:18:02.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.5, indicating a new release, while the previous version 2.16.4 has been removed. Additionally, information regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    5%
    Check dated 2025-07-04T03:50:38.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    4%
    Check dated 2025-06-19T19:29:34.000Z thumbnail image
  5. Check
    29 days ago
    No Change Detected
  6. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T11:03:56.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T05:47:57.000Z thumbnail image
  8. Check
    50 days ago
    Change Detected
    Summary
    The content regarding 'STK-012 Monotherapy and in Combination Therapy in Patients With Solid Tumors' has been added to the page, indicating a potential update or introduction of new information related to this treatment.
    Difference
    0.3%
    Check dated 2025-05-22T02:17:23.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.